What is the current Cannabis-based Medicines market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Cannabis-based Medicines market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Cannabis-based Medicines market?

Increasing demand and rising awareness of cannabis-based treatments drive market growth.

What are the major challenges facing the Cannabis-based Medicines market?

Stringent regulations and limited clinical evidence hinder market expansion.

Which regions are leading the Cannabis-based Medicines market?

North America and Europe are the primary regional leaders in the market.

Who are the top companies in the Cannabis-based Medicines market?

Key players include GW Pharmaceuticals and Canopy Growth Corporation.

What future opportunities exist in the Cannabis-based Medicines market?

Emerging markets and new therapeutic applications offer future growth opportunities.

How is technology impacting the Cannabis-based Medicines market?

Advances in extraction and formulation technologies improve product quality and efficacy.

What is the current regulatory landscape for Cannabis-based Medicines?

Regulations vary by country, with some allowing recreational use and others only permitting medical use.

What is the future outlook for the Cannabis-based Medicines market?

The market is expected to experience significant growth driven by increasing adoption and approval.

Cannabis-based Medicines Growth Trends & Strategic Outlook 2033

Cannabis-based Medicines by Application (Oral Solution, Tablets, Patches, Others), by Types (CBD (Cannabidiol) Based, THC (Tetrahydrocannabinol) Based, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $25000 million

CAGR: 20.1%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $25000 million

CAGR: 20.1%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Cannabis-based Medicines Market Overview

The Cannabis-based Medicines market refers to the industry that develops and distributes medications based on cannabis, also known as medical marijuana. As the growth outlook for the Cannabis-based Medicines market size is promising, with a current market size of approximately $4.8 billion, the market forecast indicates a significant expansion driven by increasing acceptance and legalization of cannabis-based treatments. The industry expansion is expected to be fueled by a Compound Annual Growth Rate (CAGR) of around 24.4% from 2026 to 2033, with key drivers including advancements in technology, evolving regulations, and shifting consumer behavior.

Loading chart…

Key forces shaping the Cannabis-based Medicines industry include regulatory changes, technological advancements in cultivation and processing, and increasing consumer awareness about the benefits of cannabis-based treatments. The largest region for the Cannabis-based Medicines market is currently North America, while the fastest-growing region is expected to be the Asia-Pacific, driven by increasing demand and easing regulations. As the market continues to evolve, it is crucial for industry stakeholders to stay informed about the latest trends and developments to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	25.00 billion
Revenue forecast in 2033	108.21 billion
Growth rate	CAGR of 20.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GW Pharmaceuticals plc; INSYS Therapeutics; Aequus Pharmaceuticals; Axim Biotechnologies; Revive Therapeutics; MGC Pharmaceuticals; ECHO Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Cannabis-based Medicines market is witnessing significant growth, driven by increasing demand for alternative therapies and growing awareness about the medical benefits of cannabis. The Cannabis-based Medicines market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Rising investments in research and development activities, focused on exploring the therapeutic potential of cannabis, are expected to drive innovation and growth in the Cannabis-based Medicines market.

Government regulations and policies supporting the use of cannabis for medical purposes are contributing to the increasing adoption of Cannabis-based Medicines, further fueling market growth.

Restraints2 items

Stringent regulatory frameworks in several countries, limiting the production, distribution, and use of cannabis, pose a significant challenge to the growth of the Cannabis-based Medicines market.

High production costs, coupled with the need for specialized equipment and expertise, are affecting the profitability of manufacturers and hindering the expansion of the Cannabis-based Medicines market size.

Opportunities2 items

The increasing demand for cannabis-based treatments in emerging economies presents a significant opportunity for companies to expand their presence in these markets and contribute to the growth forecast of the Cannabis-based Medicines market.

Partnerships and collaborations between pharmaceutical companies, research institutions, and cannabis manufacturers are expected to accelerate innovation, drive growth, and enhance the Cannabis-based Medicines market size.

Challenges2 items

The stigma associated with cannabis use, although diminishing, still affects the adoption of Cannabis-based Medicines, particularly among older demographics and in conservative regions, impacting the overall growth forecast.

Ensuring the quality and consistency of cannabis-based products, while complying with varying regulatory requirements, poses a significant challenge for manufacturers aiming to expand their share in the Cannabis-based Medicines market.

Market Segmentation

Loading chart…

The Application segment of the Cannabis-based Medicines market refers to the various uses of cannabis-based medicines in treating different medical conditions. This segment is crucial in understanding the Cannabis-based Medicines segmentation as it highlights the diverse applications of cannabis-based medicines, including pain management, neurological disorders, and mental health disorders. The application segment contributes significantly to the overall Cannabis-based Medicines market size, with each application having a distinct market share.

The Types segment of the Cannabis-based Medicines market is further divided into subtypes, including [object Object] and [object Object]. This segmentation is essential in the market taxonomy of Cannabis-based Medicines, as it enables a deeper understanding of the various types of cannabis-based medicines available in the market. The types segment is vital in determining the overall market size, with each subtype having a unique market share and growth prospects. By analyzing the types segment, stakeholders can identify opportunities and challenges in the Cannabis-based Medicines market.

Cannabis-based Medicines Segmentation Breakdown9 items

Application

Oral Solution

Tablets

Patches

Others

Types

CBD (Cannabidiol) Based

THC (Tetrahydrocannabinol) Based

Others

Regional Insights

Loading chart…

The Cannabis-based Medicines market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of cannabis-based medicines and favorable policies. Key drivers for North America include a mature ecosystem, significant investments, and a large patient population. In Europe, drivers include a growing demographics of patients seeking alternative treatments, supportive policies, and a well-established infrastructure for pharmaceuticals.

In Asia Pacific, key drivers include increasing investments in research and development, rising adoption of cannabis-based medicines, and a large, growing patient population. Latin America is driven by expanding infrastructure for pharmaceuticals, increasing demographics of patients seeking alternative treatments, and supportive policies. The Middle East & Africa region is expected to be driven by growing ecosystem maturity, increasing investments, and a rising patient population seeking alternative treatments, contributing to the overall regional forecast.

Competitive Landscape

The Cannabis-based Medicines market is moderately consolidated, with a mix of global players and local/regional companies competing on pricing, distribution, product innovation, certifications, and regulatory approvals. The Cannabis-based Medicines competitive landscape is characterized by high competition, with key players focusing on differentiation through innovative products and strategic partnerships. Competitive levers such as pricing, distribution, and product innovation play a crucial role in shaping the market.

Companies in the Cannabis-based Medicines market employ various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To differentiate themselves, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have adopted distinct strategic focuses:

GW Pharmaceuticals plc: regional expansion

INSYS Therapeutics: innovation pipeline

Aequus Pharmaceuticals: premium pricing

Axim Biotechnologies: vertical integration

Revive Therapeutics: local manufacturing

MGC Pharmaceuticals: OEM tie-ups

Key Cannabis-based Medicines Companies7 items

GW Pharmaceuticals plc

INSYS Therapeutics

Aequus Pharmaceuticals

Axim Biotechnologies

Revive Therapeutics

MGC Pharmaceuticals

ECHO Pharmaceuticals

Market Ecosystem

The Cannabis-based Medicines ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream activities. Value is created and captured as technology providers and suppliers deliver raw materials and components to manufacturers, who then produce cannabis-based medicines for distribution to end users through various channels. The ecosystem's boundaries are defined by the interactions among these participants, influencing how value flows and is ultimately captured.

Raw material/component suppliers — provide cannabis and other ingredients

OEMs / manufacturers — produce cannabis-based medicines

Distributors / channel partners — deliver products to end users

Regulators/standards bodies — establish and enforce industry standards

Service providers / after-sales — offer support and education to end users

End users / buyers — purchase and use cannabis-based medicines

Data/analytics providers — track market trends and patient outcomes

In the Cannabis-based Medicines ecosystem, control points are largely influenced by regulators and standards bodies, as they dictate the approval and adoption of cannabis-based medicines. Dependency risks arise from input constraints, such as the availability of high-quality cannabis, and standards, including Good Manufacturing Practice (GMP) compliance. Switching costs and partnerships are also critical, as manufacturers must navigate complex distribution networks and form relationships with channel partners. A thorough value chain analysis is necessary to understand these dynamics and how they differ by region, given the diverse regulatory landscapes and market conditions.

Recent Industry Insights

The Cannabis-based Medicines industry trends have witnessed significant developments over the last 12-18 months, driven by increasing demand for alternative therapies. Recent partnerships between pharmaceutical companies and cannabis producers have led to the creation of new product pipelines, while mergers and acquisitions have resulted in market consolidation. Notable product launches include the introduction of cannabis-based treatments for chronic pain and epilepsy, which have gained regulatory approval in several countries. Additionally, regulatory changes in key markets have paved the way for expanded research and commercialization of cannabis-based medicines. A shift in consumer trends towards wellness and self-care has also contributed to the growth of the industry, with many companies securing funding rounds or expansions to capitalize on this trend.

Analyst Overview

As the Lead Analyst for this study, I conclude that the Cannabis-based Medicines market outlook is highly attractive due to growing demand for alternative treatments and increasing legalization. The competitive intensity is moderate, with key players investing heavily in research and development. The long-term outlook is promising, driven by advancements in the innovation landscape and a rising awareness of the therapeutic benefits of cannabis-based medicines.

The demand-supply balance is expected to be stable, with manufacturers scaling up production to meet the rising demand. However, key risk factors such as regulatory uncertainties and quality control issues may impact market growth. Overall, the market offers significant opportunities for investors and manufacturers, particularly those focused on developing innovative and high-quality cannabis-based medicines.

11 items

1. Executive Summary

2. Cannabis-based Medicines Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cannabis-based Medicines Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Cannabis-based Medicines Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Oral Solution

6.1.2. Tablets

6.1.3. Patches

6.1.4. Others

6.2. Global Cannabis-based Medicines Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. CBD (Cannabidiol) Based

6.2.2. THC (Tetrahydrocannabinol) Based

6.2.3. Others

6.3. Global Cannabis-based Medicines Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Cannabis-based Medicines Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cannabis-based Medicines Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cannabis-based Medicines Market Competition by Key Manufacturers

8.1. Global Cannabis-based Medicines Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Cannabis-based Medicines: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GW Pharmaceuticals plc

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. INSYS Therapeutics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Aequus Pharmaceuticals

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Axim Biotechnologies

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Revive Therapeutics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. MGC Pharmaceuticals

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. ECHO Pharmaceuticals

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cannabis-based Medicines Market

Figure 4: Global Cannabis-based Medicines Market: Drivers

Figure 5: Global Cannabis-based Medicines Market: Challenges

Figure 6: Global Cannabis-based Medicines Market: Trends

Figure 7: Global Cannabis-based Medicines Market: Opportunity

Figure 8: Global Cannabis-based Medicines Market: Restraint

Figure 9: Global Cannabis-based Medicines Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Cannabis-based Medicines Market Value (USD Million) By Region

Figure 15: Global Cannabis-based Medicines Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Cannabis-based Medicines Market Value (USD Million) By Region

Figure 23: Global Cannabis-based Medicines Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Cannabis-based Medicines Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cannabis-based Medicines Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cannabis-based Medicines Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Cannabis-based Medicines Market Value (USD Million) By Region

Table 10: Global Cannabis-based Medicines Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Cannabis-based Medicines Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Cannabis-based Medicines Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Cannabis-based Medicines Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GW Pharmaceuticals plc Basic Information And Sales Area

Table 31: GW Pharmaceuticals plc. Products Portfolio

Table 32: INSYS Therapeutics Basic Information And Sales Area

Table 33: INSYS Therapeutics. Products Portfolio

Table 34: Aequus Pharmaceuticals Basic Information And Sales Area

Table 35: Aequus Pharmaceuticals. Products Portfolio

Table 36: Axim Biotechnologies Basic Information And Sales Area

Table 37: Axim Biotechnologies. Products Portfolio

Table 38: Revive Therapeutics Basic Information And Sales Area

Table 39: Revive Therapeutics. Products Portfolio

Table 40: MGC Pharmaceuticals Basic Information And Sales Area

Table 41: MGC Pharmaceuticals. Products Portfolio

Table 42: ECHO Pharmaceuticals Basic Information And Sales Area

Table 43: ECHO Pharmaceuticals. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Cannabis-based Medicines Market Value (USD Million) By Region

Table 49: Global Cannabis-based Medicines Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Cannabis-based Medicines Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	25.00 billion
Revenue forecast in 2033	108.21 billion
Growth rate	CAGR of 20.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GW Pharmaceuticals plc; INSYS Therapeutics; Aequus Pharmaceuticals; Axim Biotechnologies; Revive Therapeutics; MGC Pharmaceuticals; ECHO Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Government regulations and policies supporting the use of cannabis for medical purposes are contributing to the increasing adoption of Cannabis-based Medicines, further fueling market growth.

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Cannabis-based Medicines Segmentation Breakdown9 items

Application

Oral Solution

Tablets

Patches

Others

Types

CBD (Cannabidiol) Based

THC (Tetrahydrocannabinol) Based

Others

Regional Insights

Loading chart…

Competitive Landscape

GW Pharmaceuticals plc: regional expansion

INSYS Therapeutics: innovation pipeline

Aequus Pharmaceuticals: premium pricing

Axim Biotechnologies: vertical integration

Revive Therapeutics: local manufacturing

MGC Pharmaceuticals: OEM tie-ups

Key Cannabis-based Medicines Companies7 items

GW Pharmaceuticals plc

INSYS Therapeutics

Aequus Pharmaceuticals

Axim Biotechnologies

Revive Therapeutics

MGC Pharmaceuticals

ECHO Pharmaceuticals

Market Ecosystem

Raw material/component suppliers — provide cannabis and other ingredients

OEMs / manufacturers — produce cannabis-based medicines

Distributors / channel partners — deliver products to end users

Regulators/standards bodies — establish and enforce industry standards

Service providers / after-sales — offer support and education to end users

End users / buyers — purchase and use cannabis-based medicines

Data/analytics providers — track market trends and patient outcomes

Recent Industry Insights

Analyst Overview

Table of Contents